Tenon Medical, Inc. is a healthcare company focused on developing innovative solutions for the treatment of sacroiliac joint disorders
By leveraging advanced medical technology, the company aims to improve surgical outcomes and enhance patient recovery through its minimally invasive procedures and products. Tenon Medical is committed to addressing the unmet needs of patients suffering from chronic pain related to sacroiliac joint dysfunction by providing effective, safe, and durable treatment options, thus contributing to the ongoing advancement of orthopedic and pain management practices.
LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has entered into a securities purchase agreement with a single healthcare focused institutional investor for the issuance and sale of 1,271,500 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules at a purchase price of $2.00.
Stay updated with the latest market activity on Tuesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has entered into a securities purchase agreement with a single healthcare focused institutional investor for the issuance and sale of 733,500 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules at a purchase price of $2.00.
Tenon shares are moving higher on Tuesday on possible continued strength after the company announced yesterday that it received FDA 510(k) clearance for an expanded application of the company's Catamaran Sacroiliac Joint Fusion System.
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
